Willis Towers Watson (WLTW) investor relations material

Executive summary

• Achieved strong Q4 and full-year organic revenue growth of 6% and 5%, respectively, with margin expansion driven by strategic focus, talent investment, and portfolio optimization.

• Strategic acquisitions (Newfront, Cushon, FlowStone) and the TRANZACT divestiture enhanced the business mix and growth profile.

• Digital platforms, data analytics, and AI-driven efficiency initiatives supported margin expansion.

• Returned $1.65B to shareholders via share repurchases and paid $350M–$358M in dividends in 2025.

• Net income for the year was $1.61B, rebounding from a prior year loss due to impairment charges.

Financial highlights

• Q4 organic revenue growth of 6%, adjusted operating margin up 80 bps to 36.9%, and adjusted EPS of $8.12 (up 13% YoY excluding TRANZACT).

• Full-year organic growth of 5%, adjusted operating margin up 130 bps to 25.2%, and adjusted EPS of $17.08 (up 13% YoY excluding TRANZACT).

• Free cash flow for 2025 was $1.55B–$1.546B, up $279M YoY, with a margin of 15.9%.

• Q4 income from operations rose 13% to $1.016B; full-year income from operations surged 256% to $2.234B.

• Q4 revenue was $2.94B (down 3% YoY); full-year revenue was $9.71B (down 2%), primarily due to the TRANZACT sale.

Outlook and guidance

• 2026 guidance: mid-single-digit organic growth, continued margin and free cash flow expansion.

• Expecting ~100 bps annual margin expansion in Risk & Broking and incremental expansion in Health, Wealth & Career.

• Foreign exchange expected to be a $0.30 tailwind to adjusted EPS in 2026.

• At least $1B allocated to share repurchases in 2026, with ongoing evaluation of M&A opportunities.

• Newfront acquisition expected to be ~$0.10 dilutive to adjusted EPS in 2026, with $250M post-close revenue and ~26% adjusted EBITDA margin.